Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10004882HBVENSG00000110887.8protein_codingDAONoNo1610A0A024RBI1
P14920
TVIS30081291HIVENSG00000110887.8protein_codingDAONoNo1610A0A024RBI1
P14920
TVIS20050653HPVENSG00000110887.8protein_codingDAONoNo1610A0A024RBI1
P14920
TVIS44013560HTLV-1ENSG00000110887.8protein_codingDAONoNo1610A0A024RBI1
P14920
TCGA Plot Options
Drug Information
GeneDAO
DrugBank IDDB02838
Drug Name3,4-Dihydro-2h-Pyrrolium-5-Carboxylate
Target IDBE0004141
UniProt IDP14920
Regulation Type
PubMed IDs17139284; 17016423; 10592235
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsExperimental
Direct ClassificationPyrrolines
SMILES[O-]C(=O)C1=[NH+]CCC1
PathwaysHyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Ornithine Aminotransferase Deficiency (OAT Deficiency); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Hyperprolinemia Type I; Hyperprolinemia Type II; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Arginine and Proline Metabolism; D-Arginine and D-Ornithine Metabolism; Hyperornithinemia with Gyrate Atrophy (HOGA); Prolinemia Type II; L-Arginine:Glycine Amidinotransferase Deficiency; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency
PharmGKB
ChEMBLCHEMBL18591